<<Back

"Histogenics hires Cassie Shipherd Group candidate.”

The Cassie Shipherd Group is pleased to announce the successful completion of the Search for the Vice President of Regulatory/Clinical Affairs for Histogenics Corporation with the appointment of Theresa G. Wingrove, Ph.D. Histogenics, soon to be located in their new facility in Waltham, MA., is a leader in the research and development of cartilage regeneration technologies. They are entering Phase II clinical trials, and Theresa will be leading that effort.

Dr. Wingrove has extensive experience in the field of Regulatory and Clinical Affairs. Her most recent position was to lead MediSpectra in Lexington, MA. in meeting its objectives from a Regulatory and Clinical standpoint. Prior to joining MediSpectra, she spent 11 years with Pfizer-Infusaid in ever increasing positions of responsibility holding the positions of Manager Clinical Affairs, Director of Clinical Affairs and Director of the Implantable Pump Program. Prior to her experience in the Life Sciences industry, Theresa was an instructor at the University of Rochester Medical Center.

Dr. Wingrove received her B.S. in Biochemistry from Brown University and her Ph.D. in Toxicology from the University of Rochester.